Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Diphtheria Outbreak Claims 23 Lives in Jos North as Health Officials Warn of Rapid Spread

Yemi Kosoko in Jos A suspected outbreak of diphtheria has claimed at least 23 lives in Jos North Local Government Area of Plateau State, with health authorities confirming that no

A suspected outbreak of diphtheria has claimed at least 23 lives in Jos North, Plateau State, with 117 people believed to have contracted the infection. The deaths occurred within three days, prompting urgent calls for intensified health measures. Mr. Baks Bulus, Disease Surveillance and Notification Officer for Jos North, confirmed the figures and expressed concern over the rapid spread.

Diphtheria is a highly contagious bacterial infection affecting the nose, throat, and skin, spreading through close contact and shared personal items. Children with full vaccination are less likely to experience severe illness, while those unvaccinated or partially vaccinated face a higher risk. Health authorities have deployed personnel to affected communities and advised residents to maintain hygiene, avoid overcrowded places, and seek prompt medical attention.

The University of Jos's Centre of Excellence in Phytomedicine has developed a vaccine for the infection, and Jos University Teaching Hospital's Department of Microbiology can diagnose diphtheria.

Written by urgent.news from This Day's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at thisdaylive.com →

More in Health & Medicine

Andelyn to Support Manufacturing Scaleup for Genprex’s Diabetes Gene Therapy

Under the agreement, Andelyn will transition Genprex's adeno-associated virus (AAV)-based diabetes gene therapy candidate with process optimization, scale-up, and IND-enabling and clinical-stage…

  • Andelyn Biosciences to scale up manufacturing for Genprex's diabetes gene therapy
  • Therapy aims to deliver Pdx1 and MafA genes to pancreas via AAV vector
  • Andelyn's expertise to optimize processes and prepare therapy for clinical trials

More from Tuesday 1 September →